Barclays’s CureVac CVAC Stock Holding History

Barclays’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-116,000	Closed	-$1.58M	–	4848
2022 Q2	$1.58M	Buy	+116,000	New	+$1.92M	﹤0.01%	2016

Barclays's CVAC Position: Q1 2026 in Review

Barclays sold out of CureVac (CVAC) in Q1 2026, closing a stake of 2,609 shares — an estimated $11.8K sold.

Barclays first reported a position in CVAC in Q1 2022 and held it in 15 quarters. The position peaked at $1.61M in Q1 2022. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.

Barclays reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
Barclays sold 2,609 CureVac shares in Q1 2026, an estimated $11.8K.
Barclays first reported a position in CureVac in Q1 2022 and held it in 15 quarters.
Barclays's CureVac position peaked at $1.61M in Q1 2022.
0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.